The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus today after the company successfully priced and increased its US$600 million convertible bond offering, up from US$550 million due to strong global investor demand.

What did Telix Pharmaceuticals report?

• US$600 million of 1.50% convertible bonds due 2031, upsized from US$550 million
• Initial conversion price set at US$13.85 (~A$19.55) per ordinary share, a 37.5% premium to reference price
• Interest payable quarterly, beginning 22 July 2026
• Concurrent repurchase of approximately A$637 million of existing A$650 million convertible bonds due 2029
• Settlement of the new issuance and repurchase expected on 22 April 2026

What else do investors need to know?

The offering attracted strong support from both existing and new eligible investors worldwide, reinforcing Telix’s reputation in the global capital markets. The convertible bonds will be convertible into fully paid ordinary shares, providing potential upside for bondholders if Telix’s share price performs well over the next five years.

As part of its refinancing, Telix is also repurchasing and cancelling over 85% of its outstanding 2029 convertible bonds. The company intends to redeem the remaining bonds, further streamlining its capital structure and reducing refinancing risk.

What did Telix Pharmaceuticals management say?

Managing Director and Group CEO Dr. Christian Behrenbruch, said:

The successful completion of the convertible bonds refinance is in line with our capital management strategy and provides financial flexibility for Telix. We are pleased with the support we have received from both existing and new investors as part of the concurrent repurchase and new issue of convertible bonds.

What’s next for Telix Pharmaceuticals?

Looking ahead, Telix expects the completion of the bond issue and concurrent repurchase to enhance its capital management. These actions offer additional financial flexibility as the company pursues development and commercialisation of its radiopharmaceutical portfolio across multiple international markets.

Telix plans to continue investing in its late-stage clinical programmes and expansion, using the strengthened balance sheet to address unmet needs in oncology and rare diseases.

Telix Pharmaceuticals share price snapshot

Over the past 12 months, Telix shares have declined 41%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 15% over the same period.

View Original Announcement

The post Telix Pharmaceuticals upsizes convertible bonds to US$600 million appeared first on The Motley Fool Australia.

More reading

• Yancoal Australia announces $2.4bn Kestrel Coal Mine acquisition
• Telix Pharmaceuticals Investor Presentation: 56% FY25 revenue growth, pipeline advances
• 5 things to watch on the ASX 200 on Wednesday
• Qantas Airways flags higher fuel costs and capacity changes in FY26 update
• Cleanaway Waste Management trims FY26 outlook on fuel challenges

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

ASX gaming stocks have hit a rough patch. After racing to record highs in August 2025 and early 2026, the sector has pulled back sharply, with investors weighing valuation concerns against otherwise solid operating performance.

Aristocrat Leisure Ltd (ASX: ALL) is down around 19% year to date, while Light & Wonder Inc (ASX: LNW) has dropped roughly 20% over the same period.

So, is this just a cooling-off phase or a setup for the next leg higher?

Let’s take a closer look.

Aristocrat: a quality name under pressure

The $28 billion ASX gaming stock has long been one of the highest-quality names in the gaming sector. It generates the bulk of its earnings from gaming machines and digital content, particularly in the lucrative US market.

And while sentiment has softened, the underlying business hasn’t shown the same weakness. Demand for gaming machines and casino content remains resilient, especially in North America. That’s important, because it’s the engine room of Aristocrat’s earnings.

Recent data backs that up. Analysts at Macquarie Group Ltd (ASX: MQG) have pointed to year-on-year growth in US casino gaming activity. That’s a positive signal for Aristocrat’s core land-based segment.

At the same time, its digital division continues to expand, giving the company exposure to the fast-growing online gaming market. There are also positives on the capital management front. Management has been disciplined, supporting share buybacks and working to reduce debt. That focus can improve earnings quality over time.

Macquarie remains bullish on the ASX gaming stock. The broker has retained its outperform rating and set a $63.00 price target on the stock, implying potential upside of around 35% from current levels.

In other words, the market may be underestimating the strength of Aristocrat’s underlying business.

Light & Wonder: diversified and gaining ground

Light & Wonder tells a similar story, but with a slightly different angle.

The company operates across three key segments: land-based gaming, iGaming, and social gaming through its SciPlay division. That diversified model allows it to generate revenue from both traditional casino floors and the rapidly growing digital gaming space.

It’s a powerful combination. By straddling physical and digital gaming, the ASX gaming stock is positioned to capture multiple growth trends at once.

And that’s a big reason why analysts are paying attention. Macquarie has named it its top pick in the Australian gaming sector, citing its ability to win market share and its “wide moat from disruption.” That’s a strong endorsement in a competitive industry.

The upside case is compelling. Macquarie has set a $205 price target on the stock, compared to its current price of $122.77. That suggests potential upside of more than 65%.

Foolish Takeaway

Of course, risks remain. Both ASX gaming stocks are still exposed to consumer spending trends. If economic conditions weaken, discretionary spending – including gaming – could come under pressure.

There’s also ongoing competition and the ever-present risk of regulatory changes in key markets.

But for now, the key takeaway is this. The pullback in these stocks appears to be driven more by sentiment and valuation resets than by a breakdown in fundamentals.

Aristocrat and Light & Wonder have both taken a hit. But their core businesses remain strong, and analysts are still firmly in their corner. If sentiment stabilises, these beaten-down ASX gaming stocks could be well placed to bounce back.

The post Down 20%, are these ASX gaming stocks ready to surge? appeared first on The Motley Fool Australia.

More reading

• Consumer discretionary shares to target for a long-term rebound
• How I’d invest $15,000 in ASX shares right now
• 2 high-quality ASX stocks to buy and hold long term
• 3 fantastic ASX shares that could help build long-term wealth
• Morgans names two ASX 200 shares to buy and one to sell this week

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Light & Wonder Inc and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Light & Wonder Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

DroneShield Ltd (ASX: DRO) shares closed 1.2% higher on Tuesday afternoon, at $3.41. The increase is welcome news for investors after the drone operator’s shares crashed 17% over the past month alone.

The shares are now up 2.4% for the year-to-date but an incredible 231% higher than 12 months ago.

It’s been a rollercoaster ride for DroneShield

There have been plenty of ups and downs for DroneShield’s shareholders over the past six months. The stock spiked at an all-time high in October last year before gradually but continually tumbling to a low of $1.72 in late-November.

The shares enjoyed a great rally in early 2026 and climbed over 42% in the first three weeks of the year. But again, investors started taking their gains off the table and the shares tumbled south again through to late-February.

News that conflict between the US and Iran has escalated significantly in late-February smashed the Australian sharemarket. But DroneShield sits firmly as a counterdone electronic warfare business. This means it was primed to absorb a jump in investor interest as governments around the world hike their defence budgets.

Despite the tailwinds, DroneShield shares have sharply corrected again over the past month.

What’s happening to DroneShield shares now?

There have been a few hints over the past couple of weeks that the war in the Middle East may be de-escalating. And each time, DroneShield’s shares take a hit amid fears that there could mean less demand for the company’s technology solutions than initially anticipated. While the war is still very much underway, discussions about a peace agreement are ongoing.

But the share price decline really picked up pace last week when DroneShield announced a leadership reshuffle. It said that its managing director, Oleg Vornik, would step down from his role effective immediately, after more than 10 years leading the business.

The company also announced that In addition, chairman Peter James will retire and not seek re-election at the company’s Annual General Meeting (AGM) in May.

While the leadership changes look good on paper, the announcement sparked investor panic and a sharp sell off of shares. 

It also raised questions about when Vornik, James, and another director sold a combined $70 million in shares in November last year. The moved sparked a collapse in the company’s share price. Investors are clearly unsettled and the shares have shed 14.5% of their value since the announcement last Tuesday. 

Are the shares a buy, sell or hold?

While investors are rattled, it doesn’t look like analysts are.

TradingView data shows that analysts ratings and target prices are unchanged. Two have a strong buy rating and one analyst with a hold rating. The average target price is $4.50, which implies a 32% upside at the time of writing. 

Some are more bullish and expect the shares to jump 47% to $5 in the next 12 months. 

The post What’s going on with the DroneShield share price? appeared first on The Motley Fool Australia.

More reading

• 3 ASX shares below $5 with huge potential
• Is now a good time to invest $5,000 into DroneShield shares?
• These are the 10 most shorted ASX shares
• Why I’d buy BHP and DroneShield shares next week
• Why is everyone talking about Sandfire, Bendigo Bank, and DroneShield shares on Thursday?

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield and is short shares of DroneShield. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The good thing about having a 10-year investment horizon is that it allows you to focus on what is likely to endure and grow over time.

One way I can do this is by looking for exchange-traded funds (ETFs) that provide exposure to long-term trends, strong underlying businesses, and markets that can continue evolving over the years ahead.

With that said, here are three ASX ETFs I would feel comfortable owning for the next decade.

BetaShares Nasdaq 100 ETF (ASX: NDQ)

The BetaShares Nasdaq 100 ETF is often described as a technology ETF, but I think that undersells what it really represents.

To me, it is a collection of businesses that sit closest to how the modern economy operates.

These are the companies shaping how people search, communicate, shop, store data, and build software. In many cases, they are not just participants in those industries, they define them.

What I find interesting is how that influence evolves. Ten years ago, the narrative around these companies was very different to today. And I suspect ten years from now, it will be different again. The common thread is that they tend to adapt faster than the industries around them.

That adaptability is what makes the NDQ ETF compelling for a long-term holding.

It is not about picking a single winner. It is about owning a group of companies that are constantly redefining what growth looks like.

Vanguard FTSE Asia Ex-Japan Shares Index ETF (ASX: VAE)

The Vanguard FTSE Asia Ex-Japan Shares Index ETF offers exposure to a part of the world that I think is still underappreciated in many portfolios.

Asia is often discussed in terms of growth, but I think it is more useful to think about it in terms of scale and momentum.

You are looking at regions with expanding middle classes, increasing urbanisation, and a growing digital economy. These trends are not new, but they are ongoing and likely to play out over a long period.

What I like about the VAE ETF is that it captures that progression without needing to pick individual countries or companies.

It provides exposure to a mix of economies at different stages of development, which I think helps balance opportunity and risk.

For a 10-year horizon, that kind of exposure can add a different dimension to a portfolio that might otherwise be heavily weighted toward Australian and US shares.

Vanguard Diversified High Growth Index ETF (ASX: VDHG)

The Vanguard Diversified High Growth Index ETF is often seen as a set and forget ETF, and I think that description holds up over the long term.

But what stands out to me is not just the diversification, it is the structure.

This ETF combines multiple asset classes, including Australian shares, international shares, and fixed income, all within a single fund. It also rebalances automatically, which removes the need for investors to make those decisions themselves.

That may sound simple, but I think it is powerful. Over a 10-year period, markets will move in different directions at different times. Having a structure that adjusts to those changes without requiring action from the investor can make it easier to stay invested.

For someone who values simplicity and consistency, I think the VDHG ETF is a top choice.

Foolish takeaway

A long-term ETF strategy comes back to owning exposures that can grow and adapt over time.

The NDQ ETF provides access to companies shaping the modern economy, the VAE ETF captures the ongoing expansion of Asian markets, and the VDHG ETF offers a diversified, all-in-one approach.

Each ETF plays a different role, but I think all three can support a portfolio built with a long-term mindset.

The post 3 top ASX ETFs I’d buy and hold for 10 years (and why) appeared first on The Motley Fool Australia.

More reading

• Are these 3 ASX tech ETFs bargain buys in April?
• How to turn $20,000 into $100,000 with ASX ETFs
• 5 Vanguard ETFs for Aussies to buy this month
• Why these ASX ETFs could be top picks for investors in their 50s
• 3 BetaShares ETFs I think can beat the market over 5 years

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended BetaShares Nasdaq 100 ETF and is short shares of BetaShares Nasdaq 100 ETF. The Motley Fool Australia has positions in and has recommended BetaShares Nasdaq 100 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Yancoal Australia Ltd (ASX: YAL) share price is in focus today following news that the company will acquire an 80% interest in the Kestrel Coal Mine, a large-scale, long-life metallurgical coal asset based in Queensland’s Bowen Basin. Key details include a binding agreement with the current owners and consideration of up to US$2.4 billion, designed to strengthen Yancoal’s position in Australian coal production.

What did Yancoal Australia report?

• Entered a binding agreement to acquire 80% of the Kestrel Coal Mine in Queensland’s Bowen Basin
• Total consideration of up to US$2.4 billion: US$1.85 billion upfront and up to US$550 million in contingent payments
• Kestrel recorded 2025 saleable production of 5.9 Mt (100% basis), with a life-of-mine plan backed by 164 Mt marketable coal reserves
• Yancoal plans to fund the deal using a mix of available cash and a US$1.2 billion syndicated acquisition loan facility
• Strategic move increases Yancoal’s pro-forma share of metallurgical coal to 22% and positions it as a leading ASX-listed coal producer

What else do investors need to know?

The acquisition is set to make Yancoal one of the largest producers of underground metallurgical coal in Australia, with increased exposure to high-demand Asian steelmaking markets. Kestrel’s mine life extends 25 years, and combined resources underpin stable, long-term output.

The deal brings operational synergies due to Kestrel’s proximity to Yancoal’s existing Queensland assets. It also diversifies Yancoal’s production profile further into metallurgical coal while maintaining a strong presence in thermal coal.

In terms of funding, Yancoal has lined up a US$200 million working capital facility, and expects to use cash flows from the broader business to meet contingent consideration payments over five years. The deal is subject to regulatory approvals, with completion targeted for the end of Q3 2026.

What did Yancoal Australia management say?

CEO of Yancoal said Sharif Burra said:

The proposed acquisition of 80% of the Kestrel Coal Mine represents a strong strategic fit for Yancoal and adds another high-quality, long-life mine to our portfolio. Kestrel delivers increased scale and diversification to Yancoal’s portfolio and is expected to contribute premium metallurgical coal into our product mix. The acquisition positions us to deliver greater value to our shareholders and consolidates Yancoal’s position as a leading Australian coal miner. We look forward to working closely with Mitsui, the joint venture partner and owner of 20% of Kestrel, in the future as co-owners of Kestrel to continue to add value to the mine, local communities and stakeholders.

What’s next for Yancoal Australia?

Yancoal expects the Kestrel acquisition to support resilient cash flows and boost its production of premium metallurgical coal, with sales mostly destined for Japanese, Korean, Indian, and Southeast Asian buyers. The company aims to complete the transaction by late Q3 2026, pending required regulatory approvals.

Looking forward, Yancoal will work to integrate the Kestrel operation into its portfolio, targeting operational improvements and ongoing due diligence to verify coal reserves and resources. The company also intends to maintain financial flexibility, enabling it to manage future growth opportunities as Australia’s coal sector evolves.

Yancoal Australia share price snapshot

Over the past 12 months, Yancoal shares have risen 48%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 15% over the same period.

View Original Announcement

The post Yancoal Australia announces $2.4bn Kestrel Coal Mine acquisition appeared first on The Motley Fool Australia.

More reading

• Telix Pharmaceuticals upsizes convertible bonds to US$600 million
• Telix Pharmaceuticals Investor Presentation: 56% FY25 revenue growth, pipeline advances
• 5 things to watch on the ASX 200 on Wednesday
• Qantas Airways flags higher fuel costs and capacity changes in FY26 update
• Cleanaway Waste Management trims FY26 outlook on fuel challenges

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

For many investors, the goal is not just growing wealth. It is generating reliable income.

The good news is that ASX exchange traded funds (ETFs) can be a simple and effective way to do this. Some provide diversification, regular distributions, and exposure to income-producing assets without the need to pick individual stocks.

With that in mind, here are three ASX ETFs that could be excellent options for income-focused investors.

Vanguard Australian Shares High Yield ETF (ASX: VHY)

The first ASX ETF that income investors may want to consider is the Vanguard Australian Shares High Yield ETF.

This fund focuses on high-dividend-paying ASX shares, many of which are household names. It typically includes exposure to major banks like Westpac Banking Corporation (ASX: WBC), miners like BHP Group Ltd (ASX: BHP), and other established businesses with strong cash flows.

One of the key attractions of the fund is its income potential. The Australian market is well known for its generous dividends, and this ETF captures that effectively.

On top of this, many of the dividends are fully franked, which can enhance after-tax returns for local investors.

While there will still be some volatility, the Vanguard Australian Shares High Yield ETF offers a straightforward way to build a core income position with exposure to reliable dividend payers.

BetaShares Global Royalties ETF (ASX: ROYL)

Another ASX ETF that could be worth considering is the BetaShares Global Royalties ETF.

This fund takes a very different approach to income. Instead of relying on traditional dividends, it invests in companies that earn royalties.

These businesses generate revenue by taking a percentage of sales from assets such as natural resources, intellectual property, and infrastructure. This can lead to highly predictable and scalable income streams.

Because royalty companies often have lower operating costs and limited capital requirements, a larger portion of their revenue can be returned to investors.

This makes the BetaShares Global Royalties ETF an interesting option for those looking to diversify their income sources beyond traditional sectors like banks and utilities.

It was recently recommended by an analyst, as we covered here.

BetaShares S&P Australian Shares High Yield ETF (ASX: HYLD)

A third ASX ETF that income investors could consider is the BetaShares S&P Australian Shares High Yield ETF.

This fund focuses on Australian companies with high dividend yields, providing exposure to a broad range of income-generating businesses across the local market.

This includes sectors such as financials, resources, and industrials, which have historically been strong dividend payers.

What makes the BetaShares S&P Australian Shares High Yield ETF appealing is its focus on maximising yield while maintaining diversification. It complements the Vanguard Australian Shares High Yield ETF by offering an alternative approach to capturing income from the Australian share market.

For investors seeking to build a portfolio centred on dividends, this ASX ETF could play an important supporting role.

This fund was recently recommended by analysts at BetaShares.

The post 3 excellent ASX ETFs for income investors to buy appeared first on The Motley Fool Australia.

More reading

• Just starting out? These 5 ASX shares could be the perfect first buy
• Up 67% in a year! The red-hot South32 share price is smashing BHP, Rio and Fortescue
• How ASX ETF investors repositioned as the Iran war shook markets
• Expert names 1 ASX ETF to buy, 1 to hold, and 1 to sell
• Guess which ASX ETF just hit an all-time high today?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group and Vanguard Australian Shares High Yield ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Getting started with investing can feel scary, especially with so many options available.

If I were starting with $10,000 today, I would focus on building a simple, well-rounded portfolio that I could hold with confidence and continue adding to over time.

Here is how I would approach it.

Start with a strong foundation

The first step for me would be building a core with broad market exchange-traded funds (ETFs).

I would start with the Vanguard Australian Shares Index ETF (ASX: VAS), which provides exposure to a large portion of the local market and includes many of the ASX’s biggest and most established companies. It also offers a steady stream of dividend income, which I think is valuable for a beginner.

Alongside that, I would add the iShares S&P 500 AUD ETF (ASX: IVV). This ETF gives exposure to the largest companies in the United States and allows me to participate in global growth trends, particularly in areas like technology and healthcare.

Together, these two ETFs would give me a solid base across both Australian and international markets.

Add quality ASX blue chip shares

Once the foundation is in place, I would look to add a few high-quality ASX shares that I would feel comfortable holding through different market conditions.

One of those would be Commonwealth Bank of Australia (ASX: CBA). It is not always cheap, but I think its strong market position and consistent profitability make it a reliable long-term holding.

I would also include Wesfarmers Ltd (ASX: WES). It is a diversified business with exposure to retail and industrial segments, and it has a track record of making disciplined decisions that support long-term growth.

To balance things further, I would add CSL Ltd (ASX: CSL). It provides exposure to global healthcare and long-term growth trends, which helps ensure the portfolio is not overly reliant on the Australian economy.

Include a growth tilt

With the core and blue chips in place, I would still want some exposure to higher-growth opportunities.

For that, I would include Xero Ltd (ASX: XRO). It operates in cloud-based accounting software and continues to expand internationally, which I think gives it a long runway for growth.

I would also add WiseTech Global Ltd (ASX: WTC), which develops logistics software used across global supply chains. Its platform is deeply embedded in customer operations, which can support recurring revenue and long-term growth.

How I would think about the allocation

If I were dividing up the $10,000, I would keep things relatively simple and focus on balance rather than exact percentages.

I would want a meaningful portion in ETFs to provide diversification and reduce risk, while also allocating a solid amount to high-quality ASX shares that can deliver stability and income over time.

At the same time, I would still include a smaller allocation to growth companies, which may be more volatile but could help drive returns over the long term.

Foolish takeaway

If I had $10,000 to invest as a beginner, I would focus on building a portfolio that is diversified, easy to understand, and capable of growing over time.

By combining ETFs like the VAS and IVV ETFs with quality ASX shares such as CBA, Wesfarmers, and CSL, and adding growth names like Xero and WiseTech, I think it is possible to create a strong starting point.

From there, the most important step is continuing to invest consistently and giving those investments time to grow.

The post How I would build the ultimate beginner portfolio with $10,000 appeared first on The Motley Fool Australia.

More reading

• What on earth’s going on with CSL shares?
• CBA shares jump another 9.5% in April: Buy, sell or hold?
• Just starting out? These 5 ASX shares could be the perfect first buy
• Why ASX investors dumped IVV ETF last month
• Have these top ASX shares been sold off too far?

Motley Fool contributor Grace Alvino has positions in CSL, Commonwealth Bank Of Australia, Vanguard Australian Shares Index ETF, and Wesfarmers. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Wesfarmers, WiseTech Global, Xero, and iShares S&P 500 ETF. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia has recommended CSL, Wesfarmers, and iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus today after the company released an investor presentation, revealing strong top-line growth in 2025. Group revenue jumping 56% year-on-year to US$804 million, and underlying profitability supported by a positive cash balance of US$142 million.

What did Telix Pharmaceuticals report?

• Group revenue of US$804 million, up 56% from FY25, meeting upgraded guidance
• Precision Medicine revenue rose 22% year on year to US$622 million
• RLS Radiopharmacies contributed US$170 million in revenue after acquisition
• Group EBITDA of US$40 million
• Positive cash balance of US$142 million as at year end
• Investment of over US$500 million across R&D and strategic initiatives

What else do investors need to know?

Telix’s commercial momentum continues, with Q1 2026 unaudited group revenue climbing 11% quarter on quarter to US$230 million. The company is progressing multiple clinical-stage assets, with four therapies now in pivotal or phase 3 trials targeting prostate, kidney, and brain cancers.

Regulatory advances have been made for new products, including Pixclara (TLX101-Px), which has a US FDA target decision date of 11 September 2026, and Illuccix accepted for review in China. Telix has also signed a new global collaboration with Regeneron to co-develop radiopharmaceutical therapies for solid tumours, bringing in US$40 million upfront with potential for further milestone payments.

What’s next for Telix Pharmaceuticals?

Looking ahead, Telix has issued FY26 revenue guidance in the range of US$950 million to US$970 million, with continued growth expected in its Precision Medicine segment and full-year contributions from recent acquisitions. R&D investment is targeted between US$200 million and US$240 million, mainly focused on advancing late-stage therapeutics and delivery of clinical milestones.

The company aims to launch new precision imaging and therapy products, complete key clinical trials, and enhance its manufacturing capacity with projects underway in Europe and Japan. Management emphasises reinvesting earnings to support long-term sustainable growth and innovation in radiopharma.

Telix Pharmaceuticals share price snapshot

Over the past 12 months, Telix shares have risen 41%, underperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 16% over the same period.

View Original Announcement

The post Telix Pharmaceuticals Investor Presentation: 56% FY25 revenue growth, pipeline advances appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Wednesday
• Qantas Airways flags higher fuel costs and capacity changes in FY26 update
• Cleanaway Waste Management trims FY26 outlook on fuel challenges
• Westpac Banking Corporation: Items impacting first-half 2026 results
• 3 quality ASX shares I’d buy while everyone else is nervous

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

There’s a big difference between investing and building an income machine.

Anyone can put money into Australian shares. But turning small, regular contributions into a portfolio that pays you $50,000 a year is about designing something with a clear end goal.

If you are investing $300 a month, here is how that journey could realistically unfold.

Think in terms of income

A $50,000 annual second income, based on a 5% dividend yield, requires a portfolio of around $1 million.

That number might seem daunting at first. But when you break it down into monthly contributions and long-term compounding, it becomes far more achievable.

In the early years, the focus should not be on dividends at all. It should be on growth.

By investing $300 each month and targeting an average return of 10% per year (not guaranteed), you are effectively building the engine that will later produce income.

At this stage, every dollar earned should be reinvested. Dividends, capital gains, everything goes back into the portfolio to accelerate growth.

Over time, this creates a compounding effect where your investments begin generating returns on top of returns.

Growing your portfolio

Compounding does not feel powerful at the beginning. But there comes a point where it starts to take over.

After 10 years, the portfolio may still feel modest. If everything goes to plan, it would sit at approximately $60,000 based on an average 10% annual return.

After 20 years, it starts to become meaningful and would have grown to almost $220,000.

But somewhere in the third decade, growth will accelerate quickly. So much so, after 30 years your portfolio would have grown to become $625,000.

After which, it would take just five more years to grow your portfolio to $1 million, all else equal.

Transitioning to income

Once the portfolio approaches a meaningful size, the strategy can begin to shift.

Instead of focusing purely on growth, you can gradually tilt toward income-producing Australian shares. This might include banks, infrastructure companies, and other reliable dividend payers like Telstra Group Ltd (ASX: TLS) or Harvey Norman Holding Ltd (ASX: HVN).

At this stage, a 5% dividend yield is the target. On a $1 million portfolio, that equates to the $50,000 annual second income target.

Small changes, big impact

While $300 a month can get you there in 35 years, small adjustments can make a big difference.

Increasing your contributions over time, even slightly, can significantly shorten the journey.

Even an extra $50 or $100 a month, or occasional lump sum investments, can accelerate progress more than most people expect.

For example, $500 a month instead of $300 a month would take 30 years (based on a 10% per annum return) to reach $1 million.

It is a long game

This strategy is not about quick wins or short-term gains.

It is about building something gradually, almost quietly, until one day it becomes meaningful.

A $50,000 annual second income from Australian shares does not come from one great investment. It comes from hundreds of small, consistent decisions made over time. And it all starts with that first $300.

The post How to invest $300 a month in Australian shares to target a $50,000 annual second income appeared first on The Motley Fool Australia.

More reading

• The ASX shares I’d buy for passive income in April and beyond
• Have Telstra shares peaked, or is there more upside ahead?
• Consumer discretionary shares to target for a long-term rebound
• These 3 ASX 200 stocks hit a 52-week low: Buy, sell or hold?
• 3 simple ASX shares to start investing today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Harvey Norman and Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

It doesn’t take much for sentiment to shift in the share market.

One week, investors are chasing momentum. The next, they are heading for the exits. But while prices can move quickly, the underlying quality of a business rarely changes overnight.

That is why it can be a smart move for investors to use periods of weakness to revisit companies they already rate highly.

Right now, a few ASX shares are starting to look very interesting.

Goodman Group (ASX: GMG)

The first ASX share that could be worth a closer look is Goodman Group.

It is easy to think of Goodman as just another property company. But that misses the bigger picture.

Goodman sits at the centre of some very powerful long-term trends. Its assets are critical to ecommerce logistics and, increasingly, data infrastructure and artificial intelligence.

As demand for data centres and high-quality industrial space continues to grow, Goodman is positioning itself to benefit. And importantly, it is not just collecting rent. It is actively developing new assets and recycling capital into higher-return opportunities.

Following its share price weakness, investors have a chance to gain exposure to these structural trends through a proven operator.

Netwealth Group Ltd (ASX: NWL)

Another ASX share that deserves attention is Netwealth.

Netwealth operates a platform that helps financial advisers manage client investments. It might not sound exciting, but the business model is incredibly powerful.

As funds under administration grow, revenue tends to follow. And because the platform is scalable, a lot of that growth flows through to earnings.

The company has been winning market share steadily, supported by strong service and technology.

While its share price has been under pressure this year, the long-term growth story remains intact. That could make it worth considering this month.

Temple & Webster Group Ltd (ASX: TPW)

A third ASX share that could be worth a look is Temple & Webster.

This is a business that has had its ups and downs, particularly as consumer spending has fluctuated. But beneath that volatility is a company that continues to build a leading online furniture platform.

The shift to online retail is still playing out, and Temple & Webster is well positioned to benefit over time.

Another positive is how management has focused on improving profitability while continuing to grow its customer base. This paints a picture of a well-run business with the potential to create value for shareholders.

And when sentiment finally turns in the tech sector, this could be one of those names that rebounds strongly.

The post These ASX shares look too good to ignore after the recent pullback appeared first on The Motley Fool Australia.

More reading

• 3 ASX 200 shares tipped to climb another 35%
• This could be the best ASX 300 stock buy today!
• The ASX shares I’d buy and forget about for 10 years
• Where to invest $10,000 in ASX shares in April
• 3 ASX 200 shares I would buy immediately if the market dips again

Motley Fool contributor James Mickleboro has positions in Goodman Group and Temple & Webster Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group, Netwealth Group, and Temple & Webster Group. The Motley Fool Australia has positions in and has recommended Netwealth Group. The Motley Fool Australia has recommended Goodman Group and Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.